Ask your doctor if this the right treatment for you. If none of these treatments work for you, the FDA has approved the drug for moderate to severe eczema called dupilumab (Dupixent). Your doctor ...
Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis ...
Dupixent is positioned as a treatment for a rare condition ... and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with ...
Biologics are some of the newest treatment options for atopic dermatitis ... that would turn on the car (inflammation). Dupilumab (Dupixent) is a biologic approved for people ages 6 months ...
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 </stron ...
Sustained disease remission was defined as complete clinical remission with completion of oral corticosteroids (OCS) taper by week 16 (off OCS treatment and only treated with Dupixent for at least ...